Oncternal Therapeutics, Inc.

NASDAQ:ONCT

0.5266 (USD) • At close December 2, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220001999
Operating Activities:
Net Income -39.479-44.17-31.333-17.225-34.188-38.418-30.439-17.724-18.703-39.411-42.111-45.906-33.29415.294-46.256-51.78-40.359-35.51-36.839-22.348-14.194-11.866-3.812-0.75
Depreciation & Amortization 0-0.0750.1690.1500.0460.0470.0280.0430.1020.3840.751.041.5731.7851.562-4.9-5.008-0.299-0.580.3570.3320.080.045
Deferred Income Tax 00-0.169-0.15000-8.163-3.0818.804-1.36601.7761.68700.034-2.172-1.024-0.639-0.804-0.55000
Stock Based Compensation 7.57.4315.8751.5560.5072.1973.1512.9572.624.4283.7332.6484.2264.8865.1743.7142.0411.2610.6390.8040.55000
Change In Working Capital 1.274-0.069-1.3-1.675-2.513-3.3373.6151.992-1.027-3.104-4.7465.231.229-2.1814.44954.5025.53227.421.4676.4530.290.98100
Accounts Receivables 000000000000.972-0.298-0.2770.081-0.37-0.0560.092-0.153-54.836-12.138000
Inventory 000000000000.133-0.024-0.055-0.024-0.0140.129-0.0720.313-0.448-0.1940.15400
Accounts Payables -1.7690.9580.8160.272-4.7620.6751.3840.838-0.13-0.296-0.8990.4880.371-0.42-1.5531.2070.278-0.0710.5070.439-0.153000
Other Working Capital 3.043-1.027-2.116-1.9472.249-4.0122.2311.154-0.897-2.808-3.8473.6371.18-1.4295.94553.6795.18127.4710.861.29812.7750.82700
Other Non Cash Items -1.4590.1790.169-0.15119.4480.1660.1660.1320.1130.4220.1350.169-8.066-51.786-11.149-10.9572.2241.4010.8520.8040.5503.7320.705
Operating Cash Flow -32.164-36.704-26.589-17.495-16.746-39.346-23.46-20.778-20.035-28.759-43.971-37.109-33.089-30.527-45.997-2.925-37.634-11.46-34.819-15.671-12.997-10.55300
Investing Activities:
Investments In Property Plant And Equipment 000000-0.002-0.09-0.004-0.005-0.032-0.142-0.054-0.095-0.6-2.905-1.736-0.578-0.935-1.174-0.108-0.31300
Acquisitions Net 000016.1370-24.159-37.645-71.434-10.69018.897-2.45-16.944-2.45000000000
Purchases Of Investments -64.349-26.498000-44.155-39.283-35.404-55.219-41.905-1.425-11.98-15.145-8.569-11.275000000000
Sales Maturities Of Investments 65000072.03824.15937.64571.43410.699.2714.634.916.9442.45000000000
Other Investing Activites 0-26.49800-2.15572.03824.15937.64571.43410.691.42414.632.4516.9442.450-0.513-0.24-0.446-4.8260000
Investing Cash Flow 0.651-26.4980016.13727.883-15.1262.15116.211-31.229.23721.405-10.2998.28-9.425-2.905-1.736-0.578-1.381-6-0.108-0.31300
Financing Activities:
Debt Repayment 0000.30100000-0.002-0.007-0.082-0.085-0.088-0.005-0.005-0.005-0.005-0.00400000
Common Stock Issued 1.2249.5820.617113.8760.00124.47445.64813.692063.9490048.98240.2880019.17757.57945.6971.86319.987000
Common Stock Repurchased -0.156-0.0030000000000000000000000
Dividends Paid 0000000000000000000-0.455-3.436000
Other Financing Activities 000.6170.0040.015-0.569-0.156-0.2110-0.6171.2260.0850.0550.0090.1361.1670.82600-0.433-1.03810.95700
Financing Cash Flow 1.0689.5790.617114.1810.01523.90545.49213.481063.331.2190.00348.95240.2090.1311.16219.99857.57445.68671.4318.94910.95700
Other Information:
Effect Of Forex Changes On Cash 0000000000000000.03400000000
Net Change In Cash -30.445-53.623-25.97296.686-0.59412.4426.906-5.146-3.8243.351-33.515-15.7015.56417.962-55.291-4.668-19.37245.5369.48649.7595.8440.09100
Cash At End Of Period 6.69737.14290.765116.73720.05128.25815.8168.9114.05617.8814.52948.04463.74558.18140.21995.51100.178119.5574.01464.52814.7698.92500